CommercialCoverageMedium impact
06.02.55b, Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, or Antiepileptics
Independence Blue Cross·Psychiatry, Neurology, Family Medicine +1 more·Pharmacy
Effective date
Jun 25, 2025
We identified it
Jun 19, 2026
Summary
Insurance policy 06.02.55b regarding Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, or Antiepileptics has been reissued with updates effective June 25, 2025. This affects commercial insurance plans and may impact billing procedures for drug monitoring services in psychiatric and neurological care.
Action Required
Before June 25, 2025: Billing team must review the full policy details at the provided URL to understand specific changes to therapeutic drug monitoring requirements. Update billing procedures for antidepressant, antipsychotic, and antiepileptic drug monitoring services for commercial patients. Coordinate with providers who order these monitoring services to ensure compliance with new policy requirements.